Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-067439)

Filing Details

Accession Number:: 0001209191-21-067439
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-02 13:15:17
Reporting Period:: 2021-11-30

Accepted Time:: 2021-12-02 13:15:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1668243	Urogen Pharma Ltd.	URGN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363812	Molly Henderson	400 Alexander Park Drive Princeton NJ 08540	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2021-11-30	5,000	$0.00	7,500	No	4	M	Direct
Ordinary Shares	Disposition	2021-11-30	2,587	$12.03	4,913	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units	Disposition	2021-11-30	5,000	$0.00	5,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000			No	4	M	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
1/3 of the shares underlying the stock options will vest on each of November 30, 2021, October 1, 2022 and October 1, 2023.